Development of an integrated conceptual model of multiple sclerosis spasticity

被引:2
作者
Cameron, Michelle H. [1 ]
Bethoux, Francois [2 ]
Field-Fote, Edelle [3 ,4 ]
Lenderking, William R. [5 ]
Zaiser, Erica [6 ]
Cutts, Katelyn N. [5 ]
Wagner, Joanne M. [7 ,8 ]
Berwaerts, Joris [7 ,8 ]
Steinerman, Joshua R. [9 ,10 ]
机构
[1] OR Hlth & Sci Univ, Dept Neurol, Portland, OR USA
[2] Cleveland Clin, Dept Phys Med & Rehabil, Cleveland, OH USA
[3] Shepherd Ctr, Crawford Res Inst, Atlanta, GA USA
[4] Emory Univ, Dept Rehabil Med, Sch Med, Atlanta, GA USA
[5] Evidera, Waltham, MA USA
[6] Evidera, London, England
[7] Greenwich Biosci Inc, Mt Prospect, IL USA
[8] Jazz Pharmaceut, Carlsbad, CA USA
[9] Jazz Pharmaceut Inc, Philadelphia, PA USA
[10] 2005 Market St,Suite 2100, Philadelphia, PA 19103 USA
关键词
Multiple sclerosis; muscle spasticity; conceptual model; qualitative research; interviews; SPINAL-CORD-INJURY; MOBILITY IMPROVEMENT; BOTULINUM TOXIN; SYMPTOMS; BURDEN; SATIVEX; DISEASE; STROKE; IMPACT; PAIN;
D O I
10.1080/09638288.2023.2237403
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
PurposeSpasticity is common in multiple sclerosis (MS), often leading to functional limitations and disability. We developed a conceptual model of spasticity in MS integrating expert opinion, recent literature, and experiences of clinicians and people with MS spasticity.MethodsA conceptual model was developed based on a targeted literature review of articles published between 2014 and 2019, followed by input from clinicians, then input from participants with MS spasticity. Multidisciplinary experts on spasticity provided guidance at each step.ResultsKey concepts of the integrated spasticity conceptual model included: moderators; triggers; modifiers; treatment; objective manifestations; subjective experience; physical, functional, social, and emotional/psychological impacts; and long-term consequences. Participants with MS spasticity most frequently endorsed spasms, tightness, and pain as descriptors of spasticity. Some participants with MS spasticity had difficulty distinguishing spasticity from other MS symptoms (e.g. muscle weakness). Some triggers, emotional/psychological impacts, and long-term consequences of spasticity reported by participants with MS spasticity were not previously identified in the published literature.ConclusionsThis conceptual model of spasticity, integrating published literature with the experience of clinicians, people with MS spasticity, and experts, demonstrates the complex, multidimensional nature of MS spasticity. This model may be used to improve clinician-patient dialogue, research, and patient care.
引用
收藏
页码:2955 / 2965
页数:11
相关论文
共 50 条
  • [41] Non pharmacological interventions for spasticity in multiple sclerosis
    Amatya, Bhasker
    Khan, Fary
    La Mantia, Loredana
    Demetrios, Marina
    Wade, Derick T.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (02):
  • [42] Multiple Sklerose und SpastikMultiple Sclerosis and Spasticity
    Birgit Meister
    Akupunktur & Aurikulomedizin, 2021, 47 (4) : 36 - 38
  • [43] Effectiveness of Physiotherapy Interventions on Spasticity in People With Multiple Sclerosis: A Systematic Review and Meta-Analysis
    Etoom, Mohammad
    Khraiwesh, Yazan
    Lena, Francesco
    Hawamdeh, Mohannad
    Hawamdeh, Ziad
    Centonze, Diego
    Foti, Calogero
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2018, 97 (11) : 793 - 807
  • [44] Plantarflexor Weakness Negatively Impacts Walking in Persons With Multiple Sclerosis More Than Plantarflexor Spasticity
    Wagner, Joanne M.
    Kremer, Theodore R.
    Van Dillen, Linda R.
    Naismith, Robert T.
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2014, 95 (07): : 1358 - 1365
  • [45] A biopsychosocial model of resilience for multiple sclerosis
    Black, Rebecca
    Dorstyn, Diana
    JOURNAL OF HEALTH PSYCHOLOGY, 2015, 20 (11) : 1434 - 1444
  • [46] The effects of transcutaneous electrical nerve stimulation (TENS) on spasticity in multiple sclerosis
    Miller, L.
    Mattison, P.
    Paul, L.
    Wood, L.
    MULTIPLE SCLEROSIS JOURNAL, 2007, 13 (04) : 527 - 533
  • [47] New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids
    Smith, Paul F.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2010, 6 : 59 - 63
  • [48] Life Experiences of Patients With Multiple Sclerosis About Their Spasticity: A Phenomenological Study
    Ozkan, Ilknur
    Dunya, Cansu Polat
    Demir, Serkan
    CLINICAL NURSING RESEARCH, 2023, 32 (01) : 49 - 59
  • [49] The Broad Concept of "Spasticity-Plus Syndrome" in Multiple Sclerosis: A Possible New Concept in the Management of Multiple Sclerosis Symptoms
    Fernandez, Oascar
    Costa-Frossard, Lucienne
    Martinez-Gines, Marisa
    Montero, Paloma
    Maria Prieto, Jose
    Ramio, Lluis
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [50] BOTULINUM TOXIN FOR THE TREATMENT OF SPASTICITY IN MULTIPLE-SCLEROSIS - NEW OBSERVATIONS
    BORGSTEIN, J
    PINE, ZM
    MILLER, JR
    BRIN, MF
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 1993, 72 (06) : 364 - 368